Voyager Therapeutics Inc (NASDAQ:VYGR) price on Friday, March 21, remained unchanged to $3.88.
A look at the stock’s price movement, the close in the last trading session was $3.88, moving within a range at $3.775 and $3.92. The beta value (5-Year monthly) was 0.991 while the PE ratio in trailing twelve months stood at 5.38. Turning to its 52-week performance, $10.66 and $3.56 were the 52-week high and 52-week low respectively. Overall, VYGR moved -8.92% over the past month.
Voyager Therapeutics Inc’s market cap currently stands at around $214.20 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-10.
Analysts have a consensus estimate of 13.55M for the company’s revenue for the quarter, with a low and high estimate of 1M and 33M respectively. The average forecast suggests down to a -30.56% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 66.14M, representing a -17.32% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VYGR is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 1 recommend VYGR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VYGR’s current price about -3.78% and -17.19% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.41, while 7-day volatility ratio is 5.85% and 5.73% in the 30-day chart. Further, Voyager Therapeutics Inc (VYGR) has a beta value of 0.96, and an average true range (ATR) of 0.26. Analysts have given the company’s stock an average 52-week price target of $18, forecast between a low of $10 and high of $18. Looking at the price targets, the low is -157.73% off current price level while to achieve the yearly target high, price needs to move -363.92%. Nonetheless, investors will most likely welcome a -363.92% jump to $18 which is the analysts’ median price.
If we refocus on Voyager Therapeutics Inc (NASDAQ:VYGR), historical trading data shows that trading volumes averaged 0.41 over the past 10 days and 362.17K over the past 3 months. The company’s latest data on shares outstanding shows there are 54.54 million shares.
The 18.72% of Voyager Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 62.81% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.7 million on 2025-02-28, giving us a short ratio of 7.62. The data shows that as of 2025-02-28 short interest in Voyager Therapeutics Inc (VYGR) stood at 590.0 of shares outstanding, with shares short rising to 2.61 million registered in 2025-01-31. Current price change has pushed the stock -31.57% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VYGR stock continues to rise going into the next quarter.
